Fate Therapeutics Inc FATE:NASDAQ

Last Price$36.00NASDAQ Closing Price as of 4:00PM ET 8/10/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+2.17(6.41%)
Bid (Size)$34.85 (1)
Ask (Size)$36.04 (20)
Day Low / High$33.89 - 36.60
Volume786.5 K
Preliminary Data
Last Update Q2 2020
ValuationIndustry Range
Price / Earnings N/A
1.88597.80
Book Value 2.91
 
-32.26119.82
Earnings Per Share -$1.57
 
-74.4428.12
Price To Sales Ratio 153.25
 
0.6814.7K
Price To Book Ratio 6.10
 
N/A229.0K
Price To Tangible Book Ratio 6.10
 
0.40114.63
Price/Cash Flow Ratio N/A
4.892.3K
Price/Free Cash Flow Ratio N/A
6.28124.51
ProfileIndustry Range
Market Capitalization 2.9B
 
1.0M130.5B
Float (MRQ)95.58%
 
0.73106.55
Shares Outstanding (MRQ)75.9M
 
252.2 K1.3 B
Short Interest as a % of Float (MRQ)14.72%
 
N/AN/A
Shares Held By Institutions (MRQ)74.6M
 
0.73106.55
MarginsIndustry Range
Sales $10.6M
 
361.0K5.7B
Gross Margin N/A
-3.5K98.92
Net Profit Margin -1,102.93%
 
-500.9K1.5K
EBIT Margin -1,130.32%
 
-563.7K65.11
EBITDA Margin -1,105.11%
 
-561.2K71.75
Operating Margins -1,086.56%
 
-563.7K65.11
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K statement or press releases. MRQ = Most Recent Quarter
Financial StrengthIndustry Range
Current Ratio (MRQ)8.17
 
0.0966.40
Quick Ratio (MRQ)8.17
 
0.0966.40
Total Debt/Equity Ratio (MRQ)17.09
 
0.001,460,694.54
Debt/Common Equity Ratio (MRQ)17.09
 
0.001,460,694.54
EffectivenessIndustry Range
Return on Equity -54.22%
 
-4.3K87.77
Return on Assets -51.43%
 
-3.1K66.39
Asset Turnover 0.05
 
0.002.80
Receivables Turnover 24.61
 
0.00373.92
Inventory Turnover N/A
0.15513.00
Earnings and DividendsIndustry Range
EPS Growth Annual 27.64%
 
N/AN/A
Dividend Yield 5 Year Average 0.00%
 
0.0012.44
Current Dividend Yield 0.00%
 
0.63 3.92
Current Payout Ratio N/A
0.0061.30
*FATE does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 0.85%